BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

516 related articles for article (PubMed ID: 33459839)

  • 21. Cardiac involvement with amyloidosis: mechanisms of disease, diagnosis and management.
    Marcu CB; Niessen HW; Beek AM; Brouwer WP; Robbers LF; Van Rossum AC
    Conn Med; 2011; 75(10):581-90. PubMed ID: 22216672
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Myocardial Amyloidosis: The Exemplar Interstitial Disease.
    Fontana M; Ćorović A; Scully P; Moon JC
    JACC Cardiovasc Imaging; 2019 Nov; 12(11 Pt 2):2345-2356. PubMed ID: 31422120
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amyloid cardiomyopathy.
    Kristen AV
    Herz; 2020 May; 45(3):267-271. PubMed ID: 32107564
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiac amyloidosis: where are we today?
    Patel KS; Hawkins PN
    J Intern Med; 2015 Aug; 278(2):126-44. PubMed ID: 26077367
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases.
    Garcia-Pavia P; Rapezzi C; Adler Y; Arad M; Basso C; Brucato A; Burazor I; Caforio ALP; Damy T; Eriksson U; Fontana M; Gillmore JD; Gonzalez-Lopez E; Grogan M; Heymans S; Imazio M; Kindermann I; Kristen AV; Maurer MS; Merlini G; Pantazis A; Pankuweit S; Rigopoulos AG; Linhart A
    Eur Heart J; 2021 Apr; 42(16):1554-1568. PubMed ID: 33825853
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Cardiac amyloidosis].
    Hoyer C; Angermann CE; Knop S; Ertl G; Störk S
    Med Klin (Munich); 2008 Mar; 103(3):153-60. PubMed ID: 18344065
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiac Amyloidosis: Presentations, Diagnostic Work-up and Collaborative Approach for Comprehensive Clinical Management.
    Joury A; Gupta T; Krim SR
    Curr Probl Cardiol; 2021 Oct; 46(10):100910. PubMed ID: 34175153
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Noninvasive risk stratification of patients with transthyretin amyloidosis.
    Kristen AV; Scherer K; Buss S; aus dem Siepen F; Haufe S; Bauer R; Hinderhofer K; Giannitsis E; Hardt S; Haberkorn U; Katus HA; Steen H
    JACC Cardiovasc Imaging; 2014 May; 7(5):502-10. PubMed ID: 24726252
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Diagnostics of cardiac amyloidosis].
    Meier C; Yilmaz A
    Inn Med (Heidelb); 2023 Sep; 64(9):830-841. PubMed ID: 37553542
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Misconceptions and Facts About Cardiac Amyloidosis.
    Nguyen FD; Rodriguez M; Krittanawong C; Witteles R; Lenihan DJ
    Am J Cardiol; 2021 Dec; 160():99-105. PubMed ID: 34610875
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiac amyloidosis diagnosed by endomyocardial biopsy. Clinical, histopathological, immunohistochemical and ultrastructural studies.
    Prochorec-Sobieszek M; Bilińska ZT; Grzybowski J; Michalak E; Jakubowska E; Sobieszczańska-Małek M; Deptuch T; Walczak E; Wagner T; Walski M; Rózański J; Kiedrowski M; Lubiszewska B; Hoffman P; Rózyłło W
    Kardiol Pol; 2005 Jul; 63(7):20-35. PubMed ID: 16136426
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiac Care of Patients with Cardiac Amyloidosis.
    Itzhaki Ben Zadok O; Kornowski R
    Acta Haematol; 2020; 143(4):343-351. PubMed ID: 32408301
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The Changing Appearance of Cardiac Amyloidosis].
    Mahrholdt H; Klingel K; Sechtem U
    Dtsch Med Wochenschr; 2018 Sep; 143(18):1335-1343. PubMed ID: 30199915
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of biomarkers to diagnose and manage cardiac amyloidosis.
    Castiglione V; Franzini M; Aimo A; Carecci A; Lombardi CM; Passino C; Rapezzi C; Emdin M; Vergaro G
    Eur J Heart Fail; 2021 Feb; 23(2):217-230. PubMed ID: 33527656
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Diagnosis and treatment of cardiac amyloidosis : A position statement of the ESC working group on myocardial and pericardial diseases 2021].
    Pankuweit S; Dörr R
    Herz; 2022 Feb; 47(1):41-47. PubMed ID: 34878576
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multidisciplinary Approaches for Transthyretin Amyloidosis.
    Koike H; Okumura T; Murohara T; Katsuno M
    Cardiol Ther; 2021 Dec; 10(2):289-311. PubMed ID: 34089151
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recent advances in the noninvasive strategies of cardiac amyloidosis.
    Zhao L; Fang Q
    Heart Fail Rev; 2016 Nov; 21(6):703-721. PubMed ID: 27554493
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Amyloidosis-the Diagnosis and Treatment of an Underdiagnosed Disease.
    Ihne S; Morbach C; Sommer C; Geier A; Knop S; Störk S
    Dtsch Arztebl Int; 2020 Mar; 117(10):159-166. PubMed ID: 32295695
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amyloidosis in Heart Failure.
    Ihne S; Morbach C; Obici L; Palladini G; Störk S
    Curr Heart Fail Rep; 2019 Dec; 16(6):285-303. PubMed ID: 31782077
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Challenges and Strategies in the Diagnosis of Cardiac Amyloidosis.
    Fine NM
    Can J Cardiol; 2020 Mar; 36(3):441-443. PubMed ID: 31964561
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.